LearnBits

$龙虾 I'm watching for a breakdown below 0.045 before I even think about shorting.

$BTW We're just hanging around the mid-band. If volume picks up, could go either way.

$STAR Holding 0.168 = bullish. Losing it = dip to 0.15.

Be honest. Your biggest trade this year… was it genius or gambling? 🎲
$MU
$SKHY
$INTC

ExxonMobil Surges 5% as Massive Deepwater Oil Discovery Boosts Growth Pipeline 🛢️
$XOM.US
ExxonMobil shares climbed 5% in morning trading following the announcement of a major new deepwater oil discovery in the offshore Stabroek block. Initial appraisal well tests confirmed high-quality, hydrocarbon-bearing sandstone reservoirs, adding estimated reserves that further expand the energy giant’s low-cost production pipeline. Management emphasized that the discovery reinforces Guyana’s position as a core driver of long-term free cash flow, allowing the enterprise to maintain resilient production targets even through volatile global commodity cycles.$CL
The strong operational update provided immediate support to the broader energy sector, lifting rival integrated oil producers. Institutional investors welcomed the project’s favorable cost-of-supply economics, which offer robust profit margins regardless of broader macroeconomic fluctuations. By continuing to expand its high-margin deepwater footprint alongside disciplined capital expenditure, ExxonMobil reaffirmed its strategic focus on maximizing long-term shareholder returns through sustained dividends and aggressive share buybacks. $BZ

RWA sector kinda sleepy ngl. Volume and mcap barely moving, and that list is mostly flat or red except INJ carrying with +6.5%. One green soldier in a sea of meh. Not the vibe we had earlier fr 😴

$SOLV Feels like a cool-off coming. I'll buy the dip if it comes.

Nvidia’s Earnings Could Move $280 Billion in Market Value 🚀

Nvidia is heading into one of the biggest earnings events of the year, and options traders are preparing for a huge move. The market is pricing in a potential 5.4% swing in Nvidia shares after Wednesday’s results, which could translate into roughly $280 billion in market value.

The stakes are massive because Nvidia has become the market’s clearest gauge of AI demand. Investors want fresh evidence that hyperscalers are still spending aggressively on computing infrastructure and that demand for Nvidia’s latest chips remains strong.

But the bar is already extremely high. A solid quarter may not be enough if management’s outlook fails to exceed expectations. Investors will be watching revenue growth, margins, AI-chip demand and guidance for the next quarter.

The pressure is even greater after rising bond yields recently weighed on technology stocks. Higher yields can make expensive growth companies less attractive, meaning Nvidia may need an especially strong outlook to keep momentum going.

For investors, Wednesday’s report is much bigger than one company’s earnings. Nvidia has become a market-wide AI barometer, so a major surprise in either direction could quickly ripple through chipmakers, data-center stocks and the broader technology sector. 📊

$BTW Break it and we run to 0.50. I'm glued to this candle. 🚀

$JASMY finally broke out but that 0.00516 rejection got me second-guessing. Need to hold 0.0049 or we're back to 0.0046.

WYR – Stock edition. No cheating. Pick ONE and comment why! 👇
$SNDK
$MSTR
$SPCX

Alpha section going absolutely nuts rn 🔥. 61% and 43% back to back is crazy work. Feels like free money hours.

Low caps pumping hard, love this energy fr 🚀

Pullback mode is back. $SPK -16%, $BOME -6.7%, $1000RATS flat at +0.7%, some coins are getting hit hard, others are holding steady.

There's room for more downside or a bounce.

This feels like profit taking after the recent runs, not a full blown crash.

$ATH just got slapped off 0.005589. we're miles above the band. Feels like a trap.

$INJ Breakout above the band, but that 6.00 wick says no. If we lose 5.80, I'm shorting. Otherwise, we'll see.

$STORJ Feels like a classic blow-off. Taking profits if I had any.

💊 Alvotech Wins FDA Approval for Biosimilar to Denosumab.

Alvotech received U.S. Food and Drug Administration approval for AVT03, its interchangeable biosimilar to Prolia and Xgeva, both medicines developed by Amgen. The approval covers six indications related to osteoporosis and cancer-related bone complications, expanding Alvotech's presence in the U.S. biosimilars market. 🧬

AVT03 is the first interchangeable biosimilar to denosumab approved in the United States. Alvotech developed the product through its collaboration with Teva Pharmaceutical Industries, which will commercialize the medicine in the U.S. under the names Selarsdi and Stoboclo. The FDA decision adds another product to Alvotech's growing portfolio of approved biosimilars and gives patients an additional treatment option. 💊
$ALVO.US

⚡ Net Power $NPWR.US Secures 123 MW for Texas AI Power Project.

Net Power has secured the rights to acquire 123 megawatts of new gas-fired power generation equipment for Project Permian in Texas. If completed, the agreement would bring the project's potential first-phase generation capacity to nearly 200 MW, giving the company additional power-generation capacity for its planned development.

The company also signed a cost-reimbursement agreement with a prospective customer covering certain approved costs related to acquiring the equipment and developing the project. Net Power said the arrangements are designed to secure power capacity sooner while providing financial protections as Project Permian advances. The equipment agreement remains subject to customary approvals, definitive documentation and other closing conditions. 🤝

The market always rewards good research over blind hype. Where do you find your investment ideas?

$SKHYNIX
$MU
$INTC

Ethereum is stealing the spotlight from Bitcoin. ⚡

Ethereum has gained roughly 30% over the past week, significantly outperforming Bitcoin during the latest crypto rebound. CoinDesk reports that the ETH-to-BTC ratio has also formed a bullish golden cross, a technical signal that suggests Ethereum's recent relative strength could continue.

The move comes after Ethereum posted its strongest weekly performance since early 2021, while Bitcoin recorded its largest weekly dollar gain ever. That puts ETH in an interesting position: investors aren't just buying crypto broadly—they're increasingly rotating toward Ethereum.

Institutional flows are adding another layer to the story. Ethereum ETFs have attracted substantial capital during the recent rally, while corporate treasury firm Bitmine bought another $81 million worth of ETH, its largest weekly purchase since early July.

The big question now is whether Ethereum can keep outperforming after such a sharp move. A golden cross is only a signal, not a guarantee—but ETH has definitely become one of the most interesting charts in crypto again.
#BitcoinOpenInterestFallsToTwoMonthLow
#BitcoinRises23.6%Weekly
$BTC
$ETH